Search

everythinglearnresearchcommunity

for

Search:↓

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Collagen XVII is important for cell functions and its absence can worsen cancer outcomes.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

IL-18 signaling helps mature Tregs move into the thymus.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Cats likely have a reactive skin condition, while dogs may have a more complex, possibly cancerous one.

CD34 marks potential stem cells in dog hair follicles.

Nestin helps identify certain melanoma cells in nodular melanoma.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Severe CCCA may be biologically and clinically different from milder forms.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.